Paolo Grassi

1.1k total citations
75 papers, 704 citations indexed

About

Paolo Grassi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Paolo Grassi has authored 75 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 24 papers in Oncology. Recurrent topics in Paolo Grassi's work include Renal cell carcinoma treatment (32 papers), Renal and related cancers (20 papers) and Cancer Genomics and Diagnostics (18 papers). Paolo Grassi is often cited by papers focused on Renal cell carcinoma treatment (32 papers), Renal and related cancers (20 papers) and Cancer Genomics and Diagnostics (18 papers). Paolo Grassi collaborates with scholars based in Italy, United States and France. Paolo Grassi's co-authors include Giuseppe Procopio, Elena Verzoni, Filippo de Braud, Johannes Novak, Corinna Schmiderer, Chlodwig Franz, Raffaele Ratta, Alessia Mennitto, Michael Weber and Ralf Steinborn and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Plant Physiology.

In The Last Decade

Paolo Grassi

70 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Grassi Italy 16 303 288 193 135 127 75 704
Chi F. Hung Taiwan 16 336 1.1× 339 1.2× 102 0.5× 84 0.6× 44 0.3× 46 898
Yonghua Shen China 15 212 0.7× 354 1.2× 214 1.1× 89 0.7× 48 0.4× 40 766
Silvia Zanon Italy 15 287 0.9× 189 0.7× 518 2.7× 283 2.1× 99 0.8× 44 923
Huaping Yang China 17 239 0.8× 277 1.0× 169 0.9× 157 1.2× 24 0.2× 46 715
Yun Yang China 16 189 0.6× 257 0.9× 154 0.8× 113 0.8× 55 0.4× 48 608
Hyung-Lae Lee South Korea 13 145 0.5× 370 1.3× 98 0.5× 75 0.6× 32 0.3× 35 702
Ziyan Chen China 15 124 0.4× 277 1.0× 86 0.4× 148 1.1× 31 0.2× 48 674
Jianjun Liu China 13 92 0.3× 405 1.4× 159 0.8× 313 2.3× 70 0.6× 35 956
Asad Ullah United States 14 111 0.4× 351 1.2× 175 0.9× 88 0.7× 39 0.3× 96 927
Victor Oreffo United Kingdom 17 244 0.8× 335 1.2× 114 0.6× 172 1.3× 36 0.3× 33 797

Countries citing papers authored by Paolo Grassi

Since Specialization
Citations

This map shows the geographic impact of Paolo Grassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Grassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Grassi more than expected).

Fields of papers citing papers by Paolo Grassi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Grassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Grassi. The network helps show where Paolo Grassi may publish in the future.

Co-authorship network of co-authors of Paolo Grassi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Grassi. A scholar is included among the top collaborators of Paolo Grassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Grassi. Paolo Grassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Xiuning, Xiaorong Dong, Herbert H. Loong, et al.. (2025). LBA75 Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC): Results from the SOHO-01 study. Annals of Oncology. 36. S1617–S1617.
2.
Le, Xiuning, Nicolas Girard, Hye Ryun Kim, et al.. (2024). PL04.03 Safety and Efficacy of BAY 2927088 In Patients with HER2-Mutant NSCLC: Expansion Cohort from the Phase I/II SOHO-01 Study. Journal of Thoracic Oncology. 19(10). S4–S4. 6 indexed citations
3.
Loong, Herbert H., Gennaro Daniele, Ticiana Leal, et al.. (2023). 1320MO Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088. Annals of Oncology. 34. S761–S762. 4 indexed citations
4.
Manzoni, Cristian, Benedetta Maria Squeo, Francesca Villafiorita‐Monteleone, et al.. (2023). Spectral Imaging of UV-Blocking Carbon Dot-Based Coatings for Food Packaging Applications. Coatings. 13(4). 785–785. 10 indexed citations
5.
Grassi, Paolo, Ludovic Doucet, Viktor Grünwald, et al.. (2017). Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents. Oncology. 92(5). 269–275. 3 indexed citations
6.
Verzoni, Elena, Agata Cova, Paola Squarcina, et al.. (2017). Broad immunomodulating effect of first-line Pazopanib in metastatic renal cell carcinoma patients. Annals of Oncology. 28. vi17–vi17. 1 indexed citations
7.
Ratta, Raffaele, Paolo Grassi, Elena Verzoni, et al.. (2016). Nivolumab in metastatic renal cell carcinoma (mRCC) patients: a real world single-center experience. Annals of Oncology. 27. iv30–iv30. 2 indexed citations
8.
Ratta, Raffaele, Roberta Zappasodi, Daniele Raggi, et al.. (2016). Immunotherapy advances in uro-genital malignancies. Critical Reviews in Oncology/Hematology. 105. 52–64. 20 indexed citations
9.
Vassallo, M., et al.. (2016). Thromboelastographic predictors of venous thromboembolic events in critically ill patients. Blood Coagulation & Fibrinolysis. 27(7). 804–811. 10 indexed citations
10.
11.
Zanardi, Elisa, Paolo Grassi, Alessia Cavo, et al.. (2015). Treatment of elderly patients with metastatic renal cell carcinoma. Expert Review of Anticancer Therapy. 16(3). 323–334. 7 indexed citations
12.
Procopio, Giuseppe, Elena Verzoni, Roberto Iacovelli, et al.. (2014). Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients. Oncology. 88(3). 133–138. 3 indexed citations
13.
14.
Procopio, Giuseppe, Elena Verzoni, Paolo Grassi, et al.. (2014). Targeted treatments in advanced renal cell carcinoma: focus on axitinib. Pharmacogenomics and Personalized Medicine. 7. 107–107. 8 indexed citations
15.
Rosati, Maria Sofia, Cristina Raimondi, G. Baciarello, et al.. (2010). Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I–II). Annals of Oncology. 22(2). 315–320. 17 indexed citations
16.
Grassi, Paolo, et al.. (2009). B-Type Natriuretic Peptide After Open-Water and Hyperbaric Chamber Exposure to 10 msw. Aviation Space and Environmental Medicine. 80(8). 716–719. 4 indexed citations
17.
Schmiderer, Corinna, Paolo Grassi, Johannes Novak, Michael Weber, & Chlodwig Franz. (2008). Diversity of essential oil glands of clary sage (Salvia sclarea L., Lamiaceae). Plant Biology. 10(4). 433–440. 59 indexed citations
18.
Gatti, Giuseppe, Paolo Grassi, L. Silvestri, & Bartolo Zingone. (2007). Critical illness polyneuropathy. Regression following cardiac operation. Interactive Cardiovascular and Thoracic Surgery. 6(3). 419–420.
19.
Mastroianni, Claudio Maria, Emilio Jirillo, Claudio De Simone, et al.. (1989). Humoral and cellular immune responses to salmonella typhi in patients with typhoid fever. Journal of Clinical Laboratory Analysis. 3(3). 191–195. 7 indexed citations
20.
Simone, Clara De, Paolo Grassi, Venusia Covelli, et al.. (1988). Inhibition of Lymphocyte‐Mediated Antibacterial Activity by Human Seminal Plasma. American Journal Of Reproductive Immunology. 17(1). 1–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi F. Hung Breakdown of academic impact, for papers by Yonghua Shen Breakdown of academic impact, for papers by Silvia Zanon Breakdown of academic impact, for papers by Huaping Yang Breakdown of academic impact, for papers by Yun Yang Breakdown of academic impact, for papers by Hyung-Lae Lee Breakdown of academic impact, for papers by Ziyan Chen Breakdown of academic impact, for papers by Jianjun Liu Breakdown of academic impact, for papers by Asad Ullah Breakdown of academic impact, for papers by Victor Oreffo
Rankless by CCL
2026